- Home
- RVMD
as 03-26-2025 3:36pm EST
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | REDWOOD CITY |
| Market Cap: | 8.7B | IPO Year: | 2020 |
| Target Price: | $67.77 | AVG Volume (30 days): | 1.3M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 13 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.58 | EPS Growth: | N/A |
| 52 Week Low/High: | $29.55 - $62.40 | Next Earning Date: | 05-07-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | 153.09% |
Latest Revolution Medicines Inc. News
RVMD Breaking Stock News: Dive into RVMD Ticker-Specific Updates for Smart Investing
Insider Monkey
20 days ago
Is Revolution Medicines, Inc. (RVMD) Among Stocks With At Least $20 Million In Insider Spending Recently?
Insider Monkey
23 days ago
Revolution Medicines, Inc. (RVMD): Among the Cash-Rich Mid Cap Stocks to Buy Now
Thomson Reuters StreetEvents
a month ago
Q4 2024 Revolution Medicines Inc Earnings Call
GuruFocus.com
a month ago
Revolution Medicines Inc (RVMD) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ...
MT Newswires
a month ago
Revolution Medicines Q4 Net Loss Narrows
GlobeNewswire
a month ago
Revolution Medicines Reports Fourth Quarter and Full Year 2024 Financial Results and Update on Corporate Progress
GuruFocus.com
a month ago
Earnings To Watch: Revolution Medicines Inc (RVMD) Reports Q4 2024 Result
GlobeNewswire
a month ago
Revolution Medicines to Participate in March 2025 Investor Conferences
Compare RVMD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "RVMD Revolution Medicines Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.